New England Journal of Medicine · 2013 · 131 citations · 14 references
MedicineEndocrinologyGeneticsCell SignalingEndocrine GeneticsSignal TransductionGenetic DisordersHormone Receptor GeneticsInherited Endocrine SyndromesMultiple Endocrine NeoplasiaPituitary Disorder GeneticsProlactin DisordersAnterior Pituitary Hormone SecretionFamilial Endocrine Tumor SyndromesHereditary Endocrine Tumor SyndromesJanus Kinase-stat Signaling ActivationLoss-of-function VariantsProlactin ReceptorsProlactin Signaling Pathways
Hyperprolactinemia that is not associated with gestation or the puerperium is usually due to tumors in the anterior pituitary gland and occurs occasionally in hereditary multiple endocrine neoplasia syndromes. Here, we report data from three sisters with hyperprolactinemia, two of whom presented with oligomenorrhea and one with infertility. These symptoms were not associated with pituitary tumors or multiple endocrine neoplasia but were due to a heterozygous mutation in the prolactin receptor gene, PRLR, resulting in an amino acid change from histidine to arginine at codon 188 (His188Arg). This substitution disrupted the high-affinity ligand-binding interface of the prolactin receptor, resulting in a loss of downstream signaling by Janus kinase 2 (JAK2) and signal transducer and activator of transcription 5 (STAT5). Thus, the familial hyperprolactinemia appears to be due to a germline, loss-of-function mutation in PRLR, resulting in prolactin insensitivity.
14
Kathryn G. Schuff, Shane T. Hentges, Michele A. Kelly et al. · Journal of Clinical Investigation · 2002 · 108 citations